A new paper in Biology Methods and Protocols, published by Oxford University Press, indicates that researchers studying SARS-CoV-2 may have developed new methods to administer
Shares in Sangamo lost 50% of their value in after-hours trading following the announcement, which came just before the close on 30 December. Credit: jayk7
Cardiff Oncology saw its stock rise after it announced positive Phase II data from its PLK1 inhibitor onvansertib in second-line metastatic pancreatic ductal adenocarcinoma (mPDAC),